"COVID passports" are already starting to roll out in some parts of the world. Here's what you need to know about how they could work as more people get vaccinated.
[MUSIC PLAYING]
Although the timeline to implement vaccine passports isn't immediately clear.
Right now, you don't have to be vaccinated against COVID-19 to travel. But how you travel may be more limited in the future if you're not vaccinated.
We also found out what to do if you misplace your card.
Pfizer asked the FDA for emergency authorization to start inoculating 12 to 15 year-olds after extremely promising study results.
Here's what to do if you test positive for the coronavirus before your second Pfizer or Moderna shot.
We consulted science to answer all your burning questions.
Your immune system is working against the virus even if you do not exhibit any symptoms.
This week’s episode of the Checking In podcast is all about COVID-19 vaccines.
And you might have to get boosters every year to protect against the coronavirus, he added.
According to our experts, this isn't the best course of action.
Many of us want to know, but we aren't quite sure how to ask. We talked to experts about the best ways to approach the question.
Here's all the info you need to know.
On Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration recommended that the United States pause its use of the Johnson & Johnson coronavirus vaccine after multiple instances of “rare and severe” blood clotting were reported. There were six reported cases of blood clots; to compare, more than 6.8 million doses of the Johnson & Johnson vaccine have been administered in the United States, making this an incredibly rare reaction. But because we’re dealing with new vaccines and a novel virus, health officials are being extremely cautious, and have concluded that it’s best to stop vaccinating people with the one-shot vaccine for now. Which might leave people who had an appointment to receive the J&J jab wondering: What now? I have a J&J appointment in an hour, and if I don’t get a vaccine because 6 people out of 6 million got blood clots after I was allowed — nay, encouraged — to take hormonal birth control for DECADES, you will be hearing about a tiny little one woman riot.— Emily Dagger (@AbbottRabbit) April 13, 2021 All federal health channels — such as mass vaccination sites and community health centers — are immediately halting administration of the Johnson & Johnson vaccine, for the time being, reports CNN. The CDC and FDA are recommending that states do the same; however, it will be up to each individual state to make that decision, as they are given separate allocations of doses. Right now, all states have halted the use of J&J until there is more information available. But because each state has a different vaccine rollout strategy, they will likely have different ways of dealing with the pause, too. In New York State, for instance, people with appointments to get the J&J vaccine will instead receive Pfizer, according to a statement from Howard Zucker, MD, the NYS Department of Health Commissioner. Many other states seem to be following suit, and plan to give people with existing appointments the Moderna or Pfizer vaccine instead. Today our Public Health team will follow CDC guidelines and pause Johnson & Johnson distribution. If you’re scheduled to receive the J&J vaccine today, please **do not cancel your appointment** We will offer you Pfizer at NRG and Moderna at our mobile sites instead.— Lina Hidalgo (@LinaHidalgoTX) April 13, 2021 But some locations are having to reschedule or cancel existing appointments now that the J&J vaccine is temporarily unavailable. In New Jersey, Gov. Phil Murphy announced: “J&J vaccine appointments will be canceled or put on hold at all New Jersey vaccination sites until further notice. The New Jersey Department of Health will work with all vaccination sites to make arrangements for the administration of an alternative two-dose vaccine.” But many sites that are distributing vaccines throughout the state have said that they won’t be canceling appointments and will be offering alternate vaccines instead. Dr. Janet Woodcock, the acting commissioner of the FDA, said in a news conference that the pause is expected to be short, only “a matter of days,” depending on on what they learn from thoroughly investigating each of the cases. The CDC is expected to convene an Advisory Committee on Immunization Practices (ACIP) to review all six instances before deciding whether the vaccine should continue to be distributed to all adults, or certain age groups or populations. Currently, there are approximately nine million more doses of the Johnson & Johnson vaccine that have been shipped out to various states, according to data from the CDC. In a statement sent to Refinery29, Johnson & Johnson said: “We are aware of the extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine…We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public.” If you have an appointment to receive the Johnson & Johnson vaccine in the coming days, keep an eye on your email and your phone to see if you receive a cancelation or rescheduling notification. You can also call your state’s vaccine hotline or your vaccine site, if you have the number, to ask for next steps. But for now, it looks like there’s a good chance you can still show up to your appointment and receive a two-dose mRNA vaccine instead of the J&J one-shot. Additional reporting by Molly Longman. Like what you see? How about some more R29 goodness, right here?Had the Johnson & Johnson Vaccine? Don't PanicJohnson & Johnson's Vaccine Isn't "Less Effective"I Helped Create The Johnson & Johnson Vaccine
No, getting vaccinated won't impact your fertility.
With the pandemic disrupting much of the traditional teen experience, 16-year-olds are encountering a modern new milestone.
As more and more people are able to get the COVID-19 vaccine, a new set of questions has emerged about how to handle your vaccination card. While there's been some debate about whether or not to laminate the card, there seems to be a growing consensus that less permanent protection is better.
You're likely already eligible, but where can you find those hard-to-snag appointments?
A new HIV vaccine has shown a 97% response rate in Phase I clinical trials. Currently, HIV affects more than 38 million people globally. If approved, this vaccine could become the first stage of a multi-step strategy to combat HIV and other viral diseases. And the next phase of clinical trials will begin to incorporate technology developed by Moderna, which was also used in Moderna’s mRNA COVID-19 vaccine. The vaccine successfully stimulated the production of rare immune cells needed to generate antibodies against HIV, which causes AIDS and interferes with the body’s ability to fight infections, reported non-profit organizations IAVI and Scripps Research. “This study demonstrates proof of principle for a new vaccine concept for HIV, a concept that could be applied to other pathogens, as well,” said William Schief, a professor and immunologist at Scripps Research and executive director of vaccine design at IAVI’s Neutralizing Antibody Center (NAC). The vaccine is meant to act as an immune primer that triggers the activation of cells via a process called “germline-targeting,” according to The European Pharmaceutical Review. Its purpose is to act as the first step in a vaccine regimen that would elicit the production of a variety of broadly neutralizing antibodies (bnAbs). Stimulating this type of response has reportedly been pursued in HIV research for decades because it could target a wide range of HIV variants. The surface of HIV has proteins called spikes. Antibodies generated by a future version of this vaccine would disable them from entering human cells. While a 97% response rate is exceptionally positive, it is important to note that this is representative of an initial study of 48 adult volunteers who enrolled in the trial. Phase I testing marks the first time a vaccine is tested on a small group of adults in order to evaluate its safety and measure immune responses. This vaccine will undergo another Phase I clinical trial. After all Phase I trials are complete, the next step is Phase II trials. According to the Centers for Disease Control and Prevention, Phase II trials expand the clinical study and give the vaccine to people similar to those for whom the new vaccine is intended. By Phase III, the vaccine is given to thousands of people to test efficacy and safety before being submitted for a rigorous approval and licensing process. Often, vaccines undergo a Phase IV in which the vaccine would go through a formal, ongoing study even after it’s been approved. “As a next step, IAVI and Scripps Research are partnering with the biotechnology company Moderna to develop and test an mRNA-based vaccine that harnesses the approach to produce the same beneficial immune cells,” the organizations said in a joint statement. “Using mRNA technology could significantly accelerate the pace of HIV vaccine development.” This article previously stated that the HIV vaccine already incorporated Moderna technology. It has been updated to reflect that the Moderna technology will be incorporated in the next round of clinical trials. Refinery29 regrets the error. Like what you see? How about some more R29 goodness, right here?What Happens If You Get COVID Between Vaccines?The Biggest Dating App Flex Is Being Vaccinated9 Common Vaccine Myths, Debunked
An infectious disease physician and immunologist answered some urgent questions about the suspension of the shot.
With vaccination rates in Europe lagging behind America, people are booking trips here to get their shots. But is it wise and will they be allowed to?
Yahoo Lifestyle